Thursday, October 20, 2011

Selenium Vitamin E supplement increase the risk of prostate cancer

We often consume food supplements containing multivitamin and minerals which purport to provide health benefits, and we even don’t come to know that they actually have harmed our health.

One of such fact is that Selenium and Vitamin E which are extensively used as food supplements are found to be increasing risk of prostate cancer in men.

These facts about vitamin E were revealed from a clinical study conducted in USA and Puerto Rico, and Canada in multicenter clinical trial which involved about 400 sites and 35000 men, the study began in 2001.
4 Groups were formed comprising more than 8000 participants in each group,

Group 1 was given selenium and vitamin E
Group 2 was given selenium and a placebo for vitamin E;
Group 3 was given vitamin E and a placebo for selenium;
Group 4 was given given only placebo of selenium and vitamin E.

Finally it was found that, the patients taking selenium or vitamin E only and vitamin E and selenium both together were more likely to develop prostate cancer, than patients who took only placebo.
The clinical research named as SELECT was actually began to find out if selenium and vitamin E impart protection from prostate cancer , a 25 % reduction in risk was the goal which was never achieved but actually it was found that about 17 % increase in cases of prostate cancer were observed in group taking vitamin E
The study was conducted by SWOG which is a network of research institutions around the world , and was funded by National Cancer Institute (NCI) & institutions of National Institutes of Health.

Selenium and chromium extensively used in many food supplements claiming to be their beneficial effects on diabetes and many other disease conditions , and surprisingly those claims are not supported with any of prompt clinical studies revealing their beneficial effects and their usefulness in the claimed indications.

Even many food supplements which are given and growth promoter and claim to help in development of children brain and intellectual activities contain selenium and chromium in trace amounts.

Why Betalactam Antibiotics require separate manufacturing aria in a pharmaceutical manufacturing company?

Transdermal drug delivery system new requirements for quality and for regulatory submissions

Good Manufacturing Practices

Liposome drug delivery system

A new vaccine for TB which can provide protection in late stage infection.

What is clinical trial protocol?

What is an artificial pacemaker device

Therapeutic Index (Therapeutic Ratio) of a drug? What is Meant by Narrow Therapeutic Index?

Microbial load limits for water for pharmaceutical use

Ultraviolet light as antimicrobial disinfectant in water for pharmaceutical use

Why water for pharmaceutical use is always kept in close loop in continuous circulation?

Ion exchange resin and its application in pharmaceutical dosage forms, and drug delivery systems.

Why Betalactam Antibiotics require a separate manufacturing aria in a pharmaceutical manufacturing company?

Chemistry behind the allergic reactions and mode of action of betalactum antibiotics

US FDA approved first oral drug to reduce Multiple Sclerosis MS relapses

US FDA limits dosage of acetaminophen to 325 mg per unit dosage form,Requires boxed warning on lables.

US FDA honours woman who rejected thalidomide and saved millions of children's from thalidomide

A Pharmaceutical exceipent Beta Cyclodextrin being used in a life saving treatment

Nanoparticles of insulin in place of painful injections in treatment for diabetes patients, transdermal , nasal drug delivery systems

Corifact becomes the first drug to treat congenital deficiency of Factor XII.

Protein which is responsible for cancer spread discovered An antisense RNA treatment or a drug could be designed to treat cancer efficiently and safely.

Novel Drugs: Cancer Chemotherapy Using Nanoparticles May Reduce Harmful Side Effects.

What is Nanotechnology, its applications in medicine and pharmaceuticals, drug developments?

No comments: